DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Gross-Goupil M. et al.
Axitinib Versus Placebo as an Adjuvant Treatment for Renal Cell Carcinoma: Results From the Phase III, Randomized ATLAS Trial.
Ann Oncol 2018;
29: 2371-2378
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.